AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Kingspan Group Plc

Board/Management Information Feb 19, 2021

Preview not available for this file type.

Download Source File

title: "The Board is pleased to report that, in general, trading for the first four months in 2007 have shown good growth over the same period last year"
author: "Pauline"
date: 2021-02-18 18:55:00+00:00
processor: python-docx+mammoth
status: success


Kingspan Group Plc

Director Appointments

19 February 2021

Kingspan Group plc, the global leader in high performance insulation and building envelope solutions, is pleased to announce the appointments of Éimear Moloney as an Independent Non-Executive Director and Paul Murtagh as a Non-Executive Director with effect from 30 April 2021.

Éimear (50) was previously a senior investment manager in Zurich Life Assurance (Irl) plc managing asset allocation and various geographic equity portfolios, and has excellent knowledge and experience of capital markets and asset management. She has a B.A. Accounting and Finance and MSc. Investment and Treasury from Dublin City University. She is a fellow of the Institute of Chartered Accountants in Ireland, and a member of the Institute of Directors in Ireland. Éimear also has strong experience in the pharma manufacturing and controls environment as a non-executive Director of Chanelle Pharmaceuticals Group. Éimear is a non-executive Director on the Boards of Hostelworld Group plc where she chairs the Audit Committee and Yew Grove REIT plc.

Paul (47) is the Chairman and CEO of Tibidabo Scientific Industries Ltd, and was formerly the Chairman and CEO of Faxitron Bioptics LLC, leading it to its successful sale in 2018.  He was also formerly the Chairman of Deerland Probiotics & Enzymes Inc.  He has an excellent understanding of the US market and has significant experience in the global build out of a variety of medical and biotech businesses.  Previously he worked in investment banking mergers & acquisitions at Merrill Lynch & Co. in New York and Sydney. He holds a BComm International from University College Dublin, and is a non-executive director of a number of private companies.

Neither Éimear Moloney nor Paul Murtagh hold any shares in the Company.

There are no disclosures required to be made pursuant to Rules 6.6.7 (2) to (6) of the Listing Rules.

Lorcan Dowd

Company Secretary

  • 353 (0)42 9698000

Talk to a Data Expert

Have a question? We'll get back to you promptly.